On March 20, 2024, bioAffinity Technologies, Inc. closed the transaction. The transaction included participation from three investors.
bioAffinity Technologies, Inc.
Equities
BIAF
US09076W1099
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 USD | -4.35% |
|
-4.72% | +64.57% |
05-15 | BioAffinity Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-15 | Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $2.4M | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+64.57% | 29.49M | |
-6.66% | 12.28B | |
+92.81% | 8.54B | |
-22.14% | 6.58B | |
+8.86% | 5.77B | |
-23.82% | 3.48B | |
+5.12% | 2.54B | |
+43.44% | 2.41B | |
-7.24% | 2.3B | |
-64.76% | 2.07B |
- Stock Market
- Equities
- BIAF Stock
- News bioAffinity Technologies, Inc.
- BioAffinity Technologies, Inc. announced that it has received $2.624 million in funding